Sensitisation Clinical Trial
Official title:
DIEP Flap Sensory Recovery Following Direct Neurotization in Breast Reconstruction - A Blinded Prospective Study
The purpose of this study is to compare the sensory return of DIEP flaps with nerve connection to DIEP flaps with no nerve connection to see which is better. This research is being done because the presence of sensation in a reconstructed breast has been shown to improve patient-related quality of life following mastectomy reconstruction and is an important safety factor for prevention of burns and other flap injuries. Unfortunately, women who have breast skin excised during mastectomy are reconstructed with a traditional DIEP flap that does not restore sensation to the skin.
The Deep Inferior Epigastric Perforator (DIEP) flap is the current standard of care in breast reconstruction. The DIEP flap does not normally have sensation restored. The presence of sensation in a reconstructed breast has been shown to improve patient-rated quality of life following mastectomy and reconstruction and is an important safety factor for prevention of burns and other flap injuries. Unfortunately, women who have breast skin excised during mastectomy are reconstructed with a traditional DIEP flap that does not restore sensation to the skin. As such, the investigators aim to perform a prospective randomized single-blinded trial to evaluate sensory return to DIEP flaps following nerve coaptation. A blinded, prospective study will be performed involving Manitoban women over 18 years undergoing bilateral breast reconstruction with DIEP flaps. The women will have one breast reconstructed in the standard of care (DIEP flap with no nerve coaptation) and one breast reconstructed with both DIEP flap and sensory nerve coaptation; the side of coaptation will be randomized. Objective sensibility to the breast will be tested pre- and post-operatively (3, 6, 12 months) using the Pressure Specified Sensory Device (PSSD). Patients will also complete the Breast Q questionnaire postoperatively. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05079607 -
Human Skin Safety Testing of a Mitopure Topical Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers
|
N/A | |
| Recruiting |
NCT06204510 -
Effects of Complex Decongestive Therapy on Proprioception, Balance and Tactile Sense
|
N/A | |
| Completed |
NCT06047704 -
The Effect of State and Trait Anxiety on Pain-pressure Threshold
|
||
| Enrolling by invitation |
NCT01473823 -
Treatment of IgE Associated Eczema With Omega-3 Long Chain Polyunsaturated Fatty Acids in Infancy and the Development of Bronchial Asthma in Childhood
|
N/A | |
| Recruiting |
NCT05145296 -
The Safety/Efficacy Of Daratumumab With Belatacept In Highly HLA-Sensitized Patients Awaiting Kidney Transplantation
|
N/A | |
| Completed |
NCT04498676 -
50 Human Subject Repeat Insult Patch Test
|
N/A | |
| Recruiting |
NCT03223844 -
Influence of Amphetamine-induced Sensitization on Dopamine Synthesis and Release
|
N/A | |
| Not yet recruiting |
NCT05704218 -
Hypersensitivity Pneumonitis of Domestic Origin
|
N/A | |
| Completed |
NCT04510675 -
Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT
|
N/A |